Featured Research

from universities, journals, and other organizations

Cellular Antacids Give Vaccines A Boost

Date:
September 13, 2005
Source:
Journal of Experimental Medicine
Summary:
Scientists in Italy have found that a drug that blocks acid buildup inside cells revs up the immune response to vaccines. Reporting in the September 19 issue of The Journal of Experimental Medicine, Vincenzo Barnaba and his team at the University of Rome show that people receiving booster shots against hepatitis B virus developed more robust immune responses if given a widely used anti-malaria drug called chloroquine.

Scientists in Italy have found that a drug that blocks acid buildupinside cells revs up the immune response to vaccines. Reporting in theSeptember 19 issue of The Journal of Experimental Medicine, VincenzoBarnaba and his team at the University of Rome show that peoplereceiving booster shots against hepatitis B virus developed more robustimmune responses if given a widely used anti-malaria drug calledchloroquine.

Related Articles


Many vaccines are made up of soluble proteins derived from dangerousviruses or bacteria. But because of the way these proteins are brokendown by cells, they do a poor job of prodding killer cells calledcytolytic T cells into action. Cytolytic T cells are responsible foridentifying and executing infected cells, so finding ways to get moreof these cells activated is an important goal for vaccine development.

Barnaba and his colleagues now show that exposing cells tochloroquine prevents the acidification of cellular compartments intowhich vaccine proteins are taken up. Normally these proteins would bedigested rapidly inside the compartment, but this is prevented bychloroquine because the degradation requires an acidic environment. Thechloroquine treatment also made the vesicles leaky, allowing theproteins to escape into the cytoplasm of the cell. From there, theycould be broken down such that small pieces of the protein aredisplayed to nearby cytolytic T cells; recognition of these smallpieces of protein activates the killer cells.

The demonstration that a single dose of chloroquine boostedhepatitis B virus-specific T cell responses in up to 70% of vaccinerecipients suggests that this readily available, oral drug might be apromising vaccine supplement.


Story Source:

The above story is based on materials provided by Journal of Experimental Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Experimental Medicine. "Cellular Antacids Give Vaccines A Boost." ScienceDaily. ScienceDaily, 13 September 2005. <www.sciencedaily.com/releases/2005/09/050913075010.htm>.
Journal of Experimental Medicine. (2005, September 13). Cellular Antacids Give Vaccines A Boost. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2005/09/050913075010.htm
Journal of Experimental Medicine. "Cellular Antacids Give Vaccines A Boost." ScienceDaily. www.sciencedaily.com/releases/2005/09/050913075010.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Breakfast Debate: To Eat Or Not To Eat?

Breakfast Debate: To Eat Or Not To Eat?

Newsy (Oct. 23, 2014) Conflicting studies published in the same week re-ignited the debate over whether we should be eating breakfast. Video provided by Newsy
Powered by NewsLook.com
Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins